Baker/Tisch Investments, LP is Director & 10% Owner at GENOMIC HEALTH INC (GHDX). They have made 5 open-market trades across 1 company since 2018, most recently 2019-03-19.
CIK 0001551137
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GHDX | 50,857 | $3.2M |
Shares reported on the most recent Form 4, priced at the 2019-03-19 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 100% | 80% |
| Avg Move | -3.6% | -17.2% | -21.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | SELL | 2019-03-19 | 2019-03-19 | $74.63 | $7.8M | -6.0% | -16.9% | -30.1% |
| GHDX | SELL | 2019-03-18 | 2019-03-19 | $74.19 | $8.1M | -6.0% | -16.9% | -30.1% |
| GHDX | SELL | 2019-03-15 | 2019-03-19 | $74.44 | $16.9M | -6.0% | -16.9% | -30.1% |
| GHDX | SELL | 2019-03-15 | 2019-03-19 | $76.57 | $235K | -6.0% | -16.9% | -30.1% |
| GHDX | SELL | 2018-11-16 | 2018-11-20 | $76.65 | $13.3M | +6.3% | -18.4% | +12.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.